Paola Rogliani
#164,591
Most Influential Person Now
Researcher
Paola Rogliani's AcademicInfluence.com Rankings
Paola Roglianicomputer-science Degrees
Computer Science
#9760
World Rank
#10239
Historical Rank
Machine Learning
#4363
World Rank
#4413
Historical Rank
Artificial Intelligence
#4715
World Rank
#4778
Historical Rank
Database
#6720
World Rank
#6956
Historical Rank
Download Badge
Computer Science
Paola Rogliani's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Paola Rogliani Influential?
(Suggest an Edit or Addition)Paola Rogliani's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. (2000) (567)
- Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules. (2004) (245)
- β2-agonist therapy in lung disease. (2013) (215)
- A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD. (2016) (201)
- Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study (2012) (190)
- Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis (2015) (152)
- Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection (2020) (146)
- Optimizing drug delivery in COPD: The role of inhaler devices. (2017) (124)
- The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections. (2016) (121)
- HLA allele frequencies and susceptibility to COVID‐19 in a group of 99 Italian patients (2020) (112)
- Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. (2016) (108)
- Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. (2012) (107)
- Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis (2018) (107)
- Asthma and comorbid medical illness (2010) (102)
- Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study. (2012) (92)
- Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. (2014) (85)
- Awake thoracoscopic biopsy of interstitial lung disease. (2013) (81)
- Translational Study Searching for Synergy between Glycopyrronium and Indacaterol (2014) (81)
- Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis (2017) (77)
- COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells (2020) (76)
- Pharmacology and Therapeutics of Bronchodilators Revisited (2019) (74)
- Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency. (1999) (72)
- Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone (2013) (72)
- Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells (2016) (70)
- Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD (2019) (66)
- High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. (2012) (66)
- Effect of lung volume reduction surgery for severe emphysema on right ventricular function. (2002) (64)
- Adherence to COPD treatment: Myth and reality. (2017) (63)
- Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside. (2015) (57)
- Withdrawal of inhaled corticosteroids in COPD: A meta-analysis. (2017) (57)
- Canakinumab for the treatment of chronic obstructive pulmonary disease. (2015) (56)
- Comorbidities of asthma: current knowledge and future research needs (2013) (56)
- HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. (2008) (56)
- Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation (2017) (55)
- Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights (2018) (53)
- LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment (2017) (53)
- Severe Asthma and Biological Therapy: When, Which, and for Whom (2019) (53)
- Defining Phenotypes in COPD: An Aid to Personalized Healthcare (2014) (52)
- Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome? (2016) (51)
- Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis (2016) (51)
- Brain natriuretic peptide: Much more than a biomarker. (2016) (50)
- Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients (2020) (50)
- Airflow obstruction: is it asthma or is it COPD? (2016) (50)
- Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis. (2017) (47)
- SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines (2021) (45)
- Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi. (2011) (43)
- Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine (2019) (42)
- Biomarkers of lung damage associated with tobacco smoke in induced sputum. (2009) (42)
- Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways. (2015) (42)
- Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement. (2010) (41)
- Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease (2015) (41)
- Are there pulmonary sequelae in patients recovering from COVID-19? (2020) (40)
- TSLP Inhibitors for Asthma: Current Status and Future Prospects (2020) (40)
- Cardiovascular disease in patients with COPD. (2015) (39)
- Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008. (2011) (39)
- Interaction between corticosteroids and muscarinic antagonists in human airways. (2016) (39)
- Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus. (2017) (39)
- α1-Antitrypsin deficiency and chronic respiratory disorders (2020) (39)
- Glucagon-Like Peptide 1 Receptor: A Novel Pharmacological Target for Treating Human Bronchial Hyperresponsiveness. (2016) (38)
- The Challenges of Precision Medicine in COPD (2017) (38)
- An update on bronchodilators in Phase I and II clinical trials (2012) (37)
- The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease (2016) (36)
- The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle. (2013) (36)
- Acute exacerbations of COPD: risk factors for failure and relapse (2017) (36)
- Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics. (2019) (35)
- Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease (2013) (34)
- LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review (2018) (34)
- Treating systemic effects of COPD. (2007) (34)
- Diabetes mellitus among outpatients with COPD attending a university hospital (2014) (34)
- Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo (2020) (34)
- Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease (2016) (33)
- Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) study (2019) (33)
- The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis (2017) (32)
- Chronic obstructive pulmonary disease and diabetes (2015) (32)
- Comparative effectiveness of drugs for chronic obstructive pulmonary disease. (2012) (31)
- Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update (2016) (31)
- Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi. (2015) (31)
- Pharmacological treatments in asthma‐affected horses: A pair‐wise and network meta‐analysis (2017) (30)
- HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells (2002) (30)
- Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view. (2008) (30)
- The impact of comorbidities on severe asthma. (2019) (29)
- Serum CA 15-3 is increased in pulmonary fibrosis. (2009) (29)
- Identification of HLA-DRPheβ47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGluβ69 (2005) (29)
- Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives (2015) (29)
- Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease (2014) (28)
- Asthma and COPD in an Italian adult population: role of BMI considering the smoking habit. (2013) (28)
- Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi. (2009) (28)
- Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease (2020) (28)
- Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies (2020) (28)
- Controversy surrounding the Sputnik V vaccine (2021) (27)
- SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis (2020) (27)
- Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways (2018) (27)
- Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi (2017) (27)
- Pharmacological treatment and current controversies in COPD (2019) (26)
- Tiotropium formulations and safety: a network meta-analysis (2017) (26)
- Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? (2020) (26)
- Monoclonal antibodies for severe asthma: Pharmacokinetic profiles. (2019) (26)
- Analysis of exhaled breath fingerprints and volatile organic compounds in COPD (2015) (26)
- Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases (2017) (26)
- Phosphodiesterase Inhibitors for Chronic Obstructive Pulmonary Disease: What Does the Future Hold? (2014) (25)
- Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist (2017) (25)
- Does bronchoscopy help the diagnosis in COVID-19 infection? (2020) (25)
- Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations. (2019) (25)
- Metabolic syndrome and risk of pulmonary involvement. (2010) (24)
- Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients. (2015) (24)
- Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how (2018) (23)
- Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients (2020) (23)
- Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease (2018) (23)
- Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies (2021) (23)
- Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD. (2012) (23)
- Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients. (2019) (23)
- Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review (2020) (23)
- Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials (2021) (22)
- Review: New perspectives in the treatment of idiopathic pulmonary fibrosis (2008) (22)
- Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD (2019) (21)
- The effect of indacaterol during an acute exacerbation of COPD. (2013) (21)
- Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. (2015) (20)
- Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD (2018) (20)
- Brain natriuretic peptide protects against hyperresponsiveness of human asthmatic airway smooth muscle via an epithelial cell-dependent mechanism. (2014) (20)
- Role of muscarinic antagonists in asthma therapy (2017) (20)
- The future of bronchodilation: looking for new classes of bronchodilators (2019) (19)
- Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi (2017) (19)
- Chronic treatment with indacaterol and airway response to salbutamol in stable COPD. (2013) (19)
- Guidance on nebulization during the current COVID-19 pandemic (2020) (19)
- Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics. (2016) (19)
- Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients (2020) (19)
- Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways. (2019) (18)
- Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis. (2019) (18)
- Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers (2019) (18)
- Impact of doxofylline in COPD: A pairwise meta-analysis. (2018) (18)
- Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis. (2018) (17)
- Advances with glucocorticoids in the treatment of asthma: state of the art (2020) (17)
- Results of unilateral lung volume reduction surgery in patients with distinct heterogeneity of emphysema between lungs. (2005) (16)
- Inhaled corticosteroids for chronic obstructive pulmonary disease (2013) (16)
- Umeclidinium for the treatment of chronic obstructive pulmonary disease (2014) (16)
- Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study (2018) (16)
- Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? (2018) (16)
- Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom (2021) (15)
- Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies. (2016) (15)
- Nonintubated surgical biopsy of undetermined interstitial lung disease: a multicentre outcome analysis. (2018) (15)
- An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network (2016) (15)
- QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease (2015) (15)
- How does race/ethnicity influence pharmacological response to asthma therapies? (2018) (15)
- A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD. (2013) (15)
- A potential role of triple therapy for asthma patients (2019) (14)
- Influence of ethnicity on response to asthma drugs (2015) (14)
- Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab (2018) (14)
- Bronchodilator therapy for chronic cough. (2017) (14)
- An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? (2018) (14)
- The latest on the role of LAMAs in asthma. (2020) (14)
- Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent (2020) (14)
- Novel glucocorticoid receptor agonists in the treatment of asthma (2015) (14)
- Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review (2020) (14)
- Embryonic gene expression in nonoverloaded ventricles of hereditary hypertrophic cardiomyopathic hamsters. (1997) (14)
- Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease (2015) (13)
- Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment. (2019) (13)
- Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study (2019) (13)
- Use of Thiols in the Treatment of COVID-19: Current Evidence (2021) (13)
- Inhaled long-acting muscarinic antagonists in asthma - A narrative review. (2021) (13)
- N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation. (2018) (13)
- Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis. (2019) (12)
- Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease (2019) (12)
- Thoracoscopic reduction pneumoplasty for severe emphysema: do pleural adhesions affect outcome? (1999) (12)
- Unilateral thoracoscopic reduction pneumoplasty for asymmetric emphysema. (1998) (12)
- Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? (2017) (12)
- Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme‐fruste of Churg‐Strauss syndrome? (2009) (12)
- Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients (2019) (12)
- Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma. (2015) (12)
- The complex care of severe emphysema: role of awake lung volume reduction surgery. (2015) (12)
- Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine (2017) (12)
- Inhaled medication: which device for which patient? (2015) (12)
- Role of statins and mevalonate pathway on impaired HDAC2 activity induced by oxidative stress in human airway epithelial cells (2018) (12)
- Treatable Mechanisms in Asthma (2021) (11)
- The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils (2016) (11)
- Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis. (2018) (11)
- Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. (2013) (11)
- LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patients (2016) (11)
- The safety of dual bronchodilation on cardiovascular serious adverse events in COPD (2018) (11)
- Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review (2020) (10)
- Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study (2019) (10)
- Treatment options for moderate-to-very severe chronic obstructive pulmonary disease (2016) (10)
- Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine (2017) (10)
- Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis (2019) (10)
- ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study (2022) (10)
- Prospects for severe asthma treatment. (2020) (10)
- Day and Night Control of COPD and Role of Pharmacotherapy: A Review (2020) (10)
- Clinical effect of corticosteroids in asthma‐affected horses: A quantitative synthesis (2018) (10)
- Atherogenic Dyslipidemia on Admission Is Associated With Poorer Outcome in People With and Without Diabetes Hospitalized for COVID-19 (2021) (10)
- Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease (2015) (10)
- Bronchodilators in subjects with asthma-related comorbidities. (2019) (10)
- Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD. (2016) (10)
- New treatments for COPD in the elderly. (2014) (10)
- Ultra-LABAs for the treatment of asthma. (2019) (10)
- Targeting IL‐5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab (2020) (9)
- Is ICS-LAMA an alternative option to treat patients with COPD? (2018) (9)
- Anaphylaxis and intimate behaviour (2017) (9)
- Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics (2019) (9)
- Depressive and anxiety symptoms in patients with SARS-CoV2 infection (2020) (9)
- Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review (2020) (9)
- The clinical use of regenerative therapy in COPD (2014) (9)
- The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review (2021) (9)
- Asthma management in a specialist setting: Results of an Italian Respiratory Society survey. (2017) (8)
- Indacaterol, glycopyrronium, and mometasone: pharmacological interaction and anti-inflammatory profile in hyperresponsive airways. (2021) (8)
- Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study (2020) (8)
- Sex differences in COPD management (2021) (8)
- Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma (2018) (8)
- Incidence of pneumomediastinum in COVID-19: A single-center comparison between 1st and 2nd wave (2021) (8)
- Disease awareness in patients with COPD: measurement and extent (2018) (8)
- The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators. (2016) (8)
- New Avenues for Phosphodiesterase Inhibitors in Asthma (2021) (8)
- An update on the pharmacotherapeutic management of lower respiratory tract infections (2017) (8)
- Combining long‐acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways (2018) (8)
- Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD. (2014) (8)
- What Could the Role of Can f 5 Allergen Be in Dog-Sensitized Patients in "Real Life"? (2017) (8)
- A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD. (2009) (8)
- Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses (2019) (8)
- Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings (2020) (8)
- Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms. (2021) (7)
- Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy? (2018) (7)
- Indacaterol for the treatment of chronic obstructive pulmonary disease (2015) (7)
- Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity (2018) (7)
- Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? (2016) (7)
- Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary disease (2018) (7)
- The role of triple therapy in the management of COPD (2020) (7)
- The prognostic role of Gender‐Age‐Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone (2019) (7)
- Monoclonal antibodies in severe asthma: is it worth it? (2019) (7)
- Can pet keeping be considered the only criterion of exposure to cat/dog allergens in the first year of life? (2016) (7)
- Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? (2018) (7)
- Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease (2020) (7)
- Minimalist video-assisted thoracic surgery biopsy of mediastinal tumors. (2016) (7)
- Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond (2014) (7)
- Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue. (2018) (7)
- First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? (2022) (7)
- Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis (2021) (6)
- Cardiovascular disease in COPD (2020) (6)
- Advances in understanding of mechanisms related to increased cardiovascular risk in COPD (2020) (6)
- Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience (2019) (6)
- Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease. (2017) (6)
- Drug interaction and chronic obstructive respiratory disorders (2020) (6)
- Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: a translational bench-to-bedside study. (2021) (6)
- SMART for the treatment of asthma: A network meta-analysis of real-world evidence. (2021) (6)
- Fluticasone furoate/vilanterol combination for the treatment of COPD and asthma. (2015) (6)
- Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes. (2019) (6)
- Happy hypoxemia, or blunted ventilation? (2021) (6)
- Dyspnea perception and neurological symptoms in non-severe COVID-19 patients (2020) (6)
- Cardiovascular Disease in Chronic Respiratory Disorders and Beyond. (2019) (6)
- Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity. (2013) (6)
- Psychological Stress, Lung Function and Exacerbation Risk in COPD: Is an Increase of Cholinergic Tone a Possible Link? (2018) (5)
- Associated Pulmonary Hypertension Is an Independent Contributor to Exercise Intolerance in Chronic Fibrosing Interstitial Pneumonias (2018) (5)
- Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in "real life"? (2017) (5)
- Benralizumab for the treatment of asthma. (2017) (5)
- Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity. (2004) (5)
- Clinical synergism of LABA/LAMA combinations in COPD patients (2017) (5)
- The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians (2020) (5)
- A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD (2018) (5)
- The Impact of Monoclonal Antibodies on Airway Smooth Muscle Contractility in Asthma: A Systematic Review (2021) (5)
- Dog allergen immunotherapy and allergy to furry animals. (2016) (5)
- Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? (2017) (5)
- Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy (2020) (5)
- Can f 5 as a suitable marker of dog allergy: Assess male dog exposure before banning it. (2019) (5)
- Pharmacological management of adult patients with acute respiratory distress syndrome (2020) (5)
- Protein tyrosin kinase and KCa++ cannel: two faces of the same coin in LABA/LAMA synergy (2017) (5)
- Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies (2021) (4)
- Double or Triple Therapy in Chronic Obstructive Pulmonary Disease (2018) (4)
- Step-up and step-down approaches in the treatment of asthma (2021) (4)
- A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study. (2019) (4)
- Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? (2016) (4)
- What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis. (2020) (4)
- Mortality in ETHOS: A Question of “Power” (2021) (4)
- Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD) (2020) (4)
- Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease (2021) (4)
- Prognostic scoring systems for clinical course and survival in idiopathic pulmonary fibrosis (2016) (4)
- Mepolizumab Effectiveness and Allergic Status in Real Life (2020) (4)
- Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase. (2016) (4)
- Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis (2022) (4)
- Disputes over the production and dissemination of misinformation in the time of COVID-19 (2021) (4)
- Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile (2020) (4)
- Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents (2018) (4)
- An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease (2021) (4)
- In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids (2017) (3)
- Dual bronchodilation for the treatment of COPD: From bench to bedside (2022) (3)
- Indacaterol/Glycopyrronium Combination for COPD (2017) (3)
- The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review (2022) (3)
- Beyond Dual Bronchodilation – Triple Therapy, When and Why (2022) (3)
- How many systemic reactions to skin prick tests could be preventable in defined conditions? (2016) (3)
- Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? (2016) (3)
- Completion lobectomy after bilateral lung volume reduction for emphysema: salvage option or fancy? (2004) (3)
- The future of inhalation therapy in chronic obstructive pulmonary disease (2022) (3)
- Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease (2018) (3)
- Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up. (2019) (3)
- Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract. (2017) (3)
- Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review (2020) (3)
- Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients. (2021) (3)
- Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma (2021) (3)
- Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies (2022) (3)
- A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. (2020) (3)
- Management of COPD patients during COVID: difficulties and experiences (2021) (3)
- Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration (2020) (3)
- Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence (2021) (3)
- Relationship between oxytocin/vasopressin and latex in obstetric surgery: how to recognize (and prevent) allergic reactions and differentiate them from side effects? (2017) (3)
- Triple Combination Inhalers in Chronic Obstructive Pulmonary Disease and Asthma (2020) (3)
- Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs (2021) (3)
- Staged unilateral lung volume reduction surgery: from mini-invasive to minimalist treatment strategies. (2018) (3)
- Pulmonary Rehabilitation in Noncystic Fibrosis Bronchiectasis (2021) (3)
- Targeting IL-5 pathway against airway hyperresponsiveness: a challenge between benralizumab and mepolizumab (2020) (3)
- Analysis of ACE2 Genetic Variants by Direct Exome Sequencing in 99 SARS-CoV-2 Positive Patients (2020) (3)
- Interaction between tiotropium bromide and olodaterol in human bronchial smooth muscle (2017) (3)
- Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma. (2022) (3)
- Ergonomical assessment of three-dimensional versus two-dimensional thoracoscopic lobectomy. (2020) (3)
- C URRENT OPINION Comorbidities of asthma: current knowledge and future research needs (2013) (2)
- Allergy in adolescent population (14-18 years) living in Campania region (Southern Italy). A multicenter study. (2019) (2)
- Quasilobar minimalist lung volume reduction surgery. (2021) (2)
- LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life (2018) (2)
- Lessons from peculiar cases of anaphylaxis: why allergists should be prepared for the unexpected. (2021) (2)
- The Future of Bronchodilators in COPD and Asthma. (2021) (2)
- Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis. (2022) (2)
- Severe asthma and long-term Benralizumab effectiveness in real-life. (2022) (2)
- Comparative studies of dual bronchodilation in COPD. (2021) (2)
- Long-lasting interaction study between RPL554 and glycopyrronium bromide on human isolated bronchi (2014) (2)
- Interaction between tiotropium bromide and olodaterol in small human airways (2017) (2)
- Letter to the Editor: Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? (2017) (2)
- Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease Overlap. (2022) (2)
- Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” (2022) (2)
- Tiotropium could provide benefits in the early stage of COPD, but further studies are needed (2018) (2)
- Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience. (2017) (2)
- Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study. (2018) (2)
- Expert guidance on the management and challenges of long-COVID syndrome: a systematic review (2022) (2)
- Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis (2022) (2)
- Emerging antibacterial and antiviral drugs for treating respiratory tract infections (2018) (2)
- Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine (2021) (2)
- Which LABA/LAMA should be chosen in COPD patients in real life? (2021) (2)
- The possible concomitant use of aeroallergen and food panels for skin prick testing might enhance the risk of generalized allergic reactions in children. (2019) (2)
- An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma (2022) (2)
- Use of mucolytics in COPD: A Delphi consensus study. (2020) (2)
- Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis. (2020) (2)
- Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review. (2021) (2)
- Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review (2022) (2)
- Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score (2022) (2)
- Interaction between RPL554 and glycopyrronium bromide in small human airways (2014) (2)
- Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence? (2021) (1)
- IND/GLY/MF: synergism in medium and small human hyperresponsive airways (2020) (1)
- Anxiety and asthma in youth. Is a stress‐induced increased cholinergic tone the possible link? (2018) (1)
- The 5T approach in asthma: Triple Therapy Targeting Treatable Traits. (2022) (1)
- Adult Cardiac Conditions (2014) (1)
- Occupational exposure to furry animals and asthma: The complex interconnection between work and everyday life. (2018) (1)
- Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma (2022) (1)
- The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset (2022) (1)
- Is Allergic Sensitization to Siberian Hamster Preventable in High-Risk Individuals Who Are Already Sensitized or Exposed to Furry Animals? (2016) (1)
- Ensifentrine. Dual phosphodiesterase PDE3/4 inhibitor, Treatment of COPD, Treatment of cystic fibrosis (2019) (1)
- Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile (2022) (1)
- Current long-acting muscarinic antagonists for the treatment of asthma (2021) (1)
- Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1. (2021) (1)
- Seasonal monitoring of serum IgE and blood eosinophil variability may lead to a better severe asthma phenotyping and to a correct biologic prescription. (2020) (1)
- Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens (2016) (1)
- Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals? (2017) (1)
- Efficacy of erdosteine, carbocysteine, and N-acetylcysteine in COPD: a comparative analysis (2019) (1)
- Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study (2022) (1)
- Sleep and wake impairment in patients with SARS-CoV2 infection (2020) (1)
- Awake Lung Biopsy for Interstitial Lung Disease (2012) (1)
- Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? (2022) (1)
- Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? (2017) (1)
- Beclomethasone, formoterol and glycopyrronium: ceiling effect in small airways of COPD patients (2020) (1)
- The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils (2016) (1)
- Asthma and comorbidities: recent advances. (2022) (1)
- Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort. (2021) (1)
- Dexamethasone in patients hospitalized with COVID-19: a NNT and NNH analysis of RECOVERY study (2021) (1)
- Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis (2022) (1)
- Gastroesophageal reflux and COPD exacerbations: Is cholinergic‐mediated oesophago‐bronchial reflex a possible link? (2016) (1)
- Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD (2015) (1)
- Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD (2019) (1)
- Role of the Hla-Dp Glu 69 and the Tnf-α Tnfa-α2 Gene Markers in Susceptibility to Beryllium Hypersensitivity (2004) (1)
- Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination (2020) (1)
- N-Acetylcysteine protects human bronchi via inhibiting neurokinin A (2017) (1)
- Mechanisms leading to the bronchorelaxant synergy of ICS/LABA/LAMA combination (2019) (1)
- Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance (2022) (1)
- Why Are Allergens Not Detected in the Bronchoalveolar Lavage Fluid of Patients Undergoing Fiberoptic Bronchoscopy? Possible Explanations. (2019) (1)
- Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options (2022) (1)
- Sex differences in adult asthma and COPD therapy: a systematic review (2022) (1)
- Cardiopulmonary exercise test in athletes and coronary diseases|Test cardiopolmonare da sforzo negli atleti e nelle patologie coronariche (2016) (1)
- LABA/LAMA combination, exercise and lung hyperinflation in COPD: a meta-analysis (2017) (1)
- Anxiety and depression in adolescents with asthma and in their parents. Is an increased basal cholinergic tone a possible further reason to explain the negative impact on asthma control? (2020) (1)
- Urgent awake thoracoscopic treatment of retained haemothorax associated with respiratory failure. (2015) (1)
- Effect of exendin-4 on lung function of diabetic patients: a preliminary report (2017) (1)
- The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma (2023) (0)
- Anxiety and asthma in inner-city black adolescents: What could be the underestimated, possible connection? (2018) (0)
- The Challenges of Precision Medicine in COPD (2017) (0)
- Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma (2019) (0)
- Brensocatib. Dipeptidyl peptidase 1 (DPP1) inhibitor, Treatment of non-cystic fibrosis bronchiectasis (2021) (0)
- Defining Phenotypes in COPD: An Aid to Personalized Healthcare (2014) (0)
- AB0273 IDENTIFICATION OF RED FLAGS FOR INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS (2022) (0)
- Unmet needs and relationship between general practitioners (GPs) and allergists living in Campania region (southern Italy). (2020) (0)
- Vats lung reduction in patients with advanced emphysema (1998) (0)
- A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD (2022) (0)
- Pharmacological characterization of the anti-inflammatory effect of mepolizumab and benralizumab in a human ex vivo model of asthma (2022) (0)
- Anti-inflammatory profile of N-acetylcysteine in human bronchi stimulated with lipopolysaccharide (2016) (0)
- Biomarkers for possible early detection and progression of idiopathic pulmonary fibrosis (2021) (0)
- Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives (2021) (0)
- CD71− Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease (2019) (0)
- Can placebo challenge test (inducing a "nocebo effect") be a suitable model to assess stress-induced bronchial obstruction? Suggestions from the multidisciplinary Working Groups "Stress-Asthma" and "AAIITO Regione Campania". (2021) (0)
- Critical interpretation of pairwise and network meta-analysis of randomized respiratory clinical trials (2019) (0)
- Once- vs. twice-daily inhaled therapy in asthma: a network meta-analysis (2019) (0)
- HSV positivity in bronco-alveolar lavage fluid and clinical outcome in hospitalized patients (2016) (0)
- Related articles (2014) (0)
- Interaction between aclidinium bromide and formoterol fumarate in small human airways (2014) (0)
- Salvage option or fancy? Completion lobectomy after bilateral lung volume reduction for emphysema: (2011) (0)
- Post-COVID Assessment of Pulmonary Function and Muscles Strength Test in Healthy Subjects (2022) (0)
- Unilateral thoracoscopic reduction pneumoplasty for asymmetric emphysema 1 Presented at the 11th Ann (1998) (0)
- Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Airway Hyperresponsiveness in a Human Ex Vivo Model of Severe Eosinophilic Asthma (2023) (0)
- Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations (2018) (0)
- Indacaterol acetate, glycopyrronium bromide, and mometasone furoate: effect on human airway inflammation (2021) (0)
- Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis (2022) (0)
- Beclomethasone, formoterol and glycopyrronium: synergy of dual and triple combinations in an ex vivo model of COPD exacerbation (2021) (0)
- Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD (2017) (0)
- PP399 Analysis Of Referral Patterns To Specialized Centers In Idiopathic Pulmonary Fibrosis To Define A New Regional Care Pathway (2020) (0)
- Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate (2016) (0)
- Bronchorelaxant effect of beclomethasone dipropionate in an ex vivo model of COPD exacerbation (2022) (0)
- Impact of glucagon-like peptide 1 receptor agonists on lung function of diabetic patients: a 52 weeks clinical trial (2018) (0)
- Social network analysis of Pseudomonas aeruginosa in cystic fi brosis (2015) (0)
- Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Inflammation in a Human Ex Vivo Model of Severe Eosinophilic Asthma (2023) (0)
- Systematic Literature Review of Treatments Used for Refractory or Unexplained Chronic Cough in Adults (2022) (0)
- Biologic therapies for chronic obstructive pulmonary disease (2022) (0)
- Tozorakimab. Anti-IL-33 monoclonal antibody, Treatment of COPD and asthma, Treatment of atopic dermatitis, Treatment of diabetic kidney disease (2023) (0)
- Highlights of high-resolution computed tomography imaging in evaluation of complications and co-morbidities in idiopathic pulmonary fibrosis (2020) (0)
- Characterization of the Solitary Pulmonary Nodule (NPS): Comparison of Positron Emission Tomography-Computer Tomography (PET-CT) and MRI in Diffusion Weighted Imaging/Apparent Diffusion Coefficient (DWI/ADC) Sequences, a Pilot Study (2023) (0)
- Influence of allergic status and nasal polyposis on long-term Benralizumab response in eosinophilic severe asthma. (2023) (0)
- Indoor environmental interventions for furry pet allergens: How to decrease the degree of passive transport. (2018) (0)
- MINIMALIST THORACOSCOPIC BIOPSY OF INTERSTITIAL LUNG DISEASE (2019) (0)
- Searching for synergistic interaction between aclidinium (ACL) and formoterol (FOR): From bench to bedside (2015) (0)
- Short term effect of DASH regiment on OSAS: results from a monocentric pilot study (2019) (0)
- A long-term (2 years) efficacy and safety study of doxofylline in the treatment of asthma (2019) (0)
- Sensitization to Cat: Why Not Use Molecular Diagnostics instead of the Nasal Challenge in Clinical Practice? (2019) (0)
- Global burden of COPD and limitations to current management strategies (2014) (0)
- Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD (2023) (0)
- Onset of action of aclidinium (ACL), glycopyrronium (GLY) and tiotropium (TIO): A comparison in COPD patients (2015) (0)
- Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab (2021) (0)
- Navafenterol. Dual M3 receptor antagonist/beta2-adrenoceptor agonist (MABA), Treatment of chronic obstructive pulmonary disease (2022) (0)
- RMHP_A_211321 43..53 (2020) (0)
- Immunogenesis of Lung Granulomatosis: New Acquisitions (1996) (0)
- Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study (2020) (0)
- Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region (2022) (0)
- Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study (2018) (0)
- Beclomethasone, formoterol and glycopyrronium: synergism of triple therapy on human airways (2019) (0)
- Mechanisms leading to the bronchoprotective effects of N-Acetylcysteine in human bronchi stimulated by lipopolysaccharide (2018) (0)
- Strength of association between comorbidities and asthma: a meta-analysis (2023) (0)
- No evidence for allelic association between Covid-19 and ACE2 genetic variants by direct exome sequencing in 99 SARS-CoV-2 positive patients (2020) (0)
- Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients (2021) (0)
- Adding glycopyrronium to beclomethasone/formoterol combination: synergistic effect on human medium bronchi of COPD donors (2021) (0)
- Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis (2018) (0)
- Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone (2016) (0)
- Role of different spirometric reference equations for lung volumes assessment (2018) (0)
- COPD_A_345263 165..180 (2022) (0)
- Long‑term management of patients with chronic obstructive pulmonary disease who undergo percutaneous coronary intervention still needs to be dramatically improved. (2018) (0)
- As needed therapies in mild to severe asthma: a systematic review and network meta-analysis (2020) (0)
- Mucolytics/antioxidants: When Are They Useful? (2023) (0)
- PROCEEDINGS of the XVI CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Lecce, Italy June 8-11, 2016 (2016) (0)
- Occupational allergy to horse allergens: More than exposure to horses! (2016) (0)
- Current and emerging treatment modalities for bacterial rhinosinusitis in adults: a comprehensive review (2022) (0)
- Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis (2022) (0)
- The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review (2022) (0)
- Indacaterol/mometasone furoate combination: synergism in human hyperresponsive airway smooth muscle (2020) (0)
- Beclomethasone, formoterol and glycopyrronium: effect on an ex vivo model of COPD exacerbation (2020) (0)
- Asthma control and psychological health in pediatric severe asthma: Why is child phenotyping necessary? Suggestions from a multidisciplinary “Stress-Asthma Working Group” (2021) (0)
- Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is mandatory. (2022) (0)
- Malattie infiltrative diffuse del polmone (2017) (0)
- Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19 (2022) (0)
- The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum] (2018) (0)
- COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients (2014) (0)
- Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models (2022) (0)
- Use of face masks and allergic rhinitis from ragweed: Why mention only total pollen count and not air pollution levels? (2021) (0)
- Impact of age on the efficacy of anti-IL-5 monoclonal antibodies in severe asthmatics (2019) (0)
- Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial (2021) (0)
- Proteomic profiling for the development of new serum based diagnostic and prognostic biomarkers in Progressive Pulmonary Fibrosis. (2022) (0)
- Evaluation of multiple antibiotic resistance (MAR) index and Doxycycline susceptibility of Acinetobacter species among inpatients (2016) (0)
- Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma (2018) (0)
- Bidimensional comparative analysis of LABA/LAMA FDCs in COPD (2019) (0)
- Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings (2022) (0)
- COPD_A_240033 1269..1285 (2020) (0)
- Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link ? (2020) (0)
- Impact of erdosteine on exacerbations in moderate COPD (2022) (0)
- BNT162b2 mRNA Covid-19 Vaccine Increases the Sensitivity to Histamine in a Human Ex Vivo Model of Severe Eosinophilic Asthma (2023) (0)
- Cardiovascular disease in asthma patients: from mechanisms to therapeutic implications. (2023) (0)
- Pharmacological characterization of the anti-oxidant activity of N-acetylcysteine in anex vivomodel of COPD exacerbation (2016) (0)
- 1 Lungcancerscreening:Shouldwebeexcludingpeoplewithpreviousmalignancy? (2016) (0)
- Corrigendum to "Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up" [Respir. Med. 153 (2019) 68-75]. (2019) (0)
- Prevalence and clinical relevance of comorbidities in IPF (2018) (0)
- Is there a maximum effect of fixed triple combination therapy to treat chronic obstructive pulmonary disease (COPD)? (2020) (0)
- heterogeneity of emphysema between lungs Results of unilateral lung volume reduction surgery in patients with distinct (2011) (0)
- P-145INTER-INSTITUTIONAL REPRODUCIBILITY OF NONINTUBATED THORACOSCOPIC SURGERY WITH ADOPTION OF A TECHNICAL EQUIPOISE STRATEGY (2017) (0)
- Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma (2019) (0)
- PGPM_A_231471 261..271 (2020) (0)
- Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression (2019) (0)
- Synergy across the drugs approved for the treatment of asthma. (2021) (0)
- BAL markers of alveolar/capillary abnormality in IPF (2012) (0)
- Multi-Dimensional Assessment in Idiopathic Pulmonary Fibrosis (2017) (0)
- Tommaso Nodules Feasibility and Results of Awake Thoracoscopic Resection of Solitary Pulmonary (2004) (0)
- Cytofluorimetric BAL cells characterization in IPF and in other ILD (2016) (0)
- Effect of ICS/LABA combination in an ex vivo model of COPD exacerbation (2020) (0)
- Surgery of giant emphysematous bullae (2005) (0)
- A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem. (2023) (0)
- Awake videothoracoscopic biopsy of diffuse lung disease. Effects on pulmonary function and oxygenation (2010) (0)
- Temporal trend of benralizumab safety profile in severe asthma: a cumulative meta-analysis (2022) (0)
- Use of face masks and allergic nasal symptoms: Why not mention pollen count and air pollution data? (2021) (0)
- Efficacy and safety of ICS/LABA/LAMA FDCs in COPD: a network meta-analysis (2022) (0)
- Qualitative aspects of exertional dyspnea in ILD patients before and after oxygen supplementation (2015) (0)
- BNT162b2 mRNA Covid-19 Vaccine Increases the Contractility to Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma (2023) (0)
- LPS-challenged equine bronchi: evidence for IL-6 as a target against AHR (2022) (0)
- Sex differences in excessive oral corticosteroid exposure in poor adherent adult asthmatics overusing short-acting β-2 agonists. (2021) (0)
- COVID-19 lockdown, personal protective equipment, hyper-hygiene and allergy. (2022) (0)
- Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study (2022) (0)
- Response. (2019) (0)
- Onset of action of formoterol/budesonide (F/B) Spiromax® compared with F/B Turbuhaler® in patients with COPD: A preliminary report (2016) (0)
- Systemic pharmacotherapy (2019) (0)
- Iconographies supplémentaires de l'article : Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients (2015) (0)
- Preliminary data of the risk stratification score (RISE) prospective, multi-centre, 3-year, validation trial in idiopathic pulmonary fibrosis. (2022) (0)
- Comparative evaluation on the synergism of roflumilast (RFL) and glycopyrronium (Gly) vs ciclesonide (CLS) and Gly on lung volumes and exercise tolerance in severe COPD (2015) (0)
- Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs (2021) (0)
- Beclomethasone protects against human airway hyperresponsiveness induced by cow’s milk aspiration (2019) (0)
- Serum ST2 in Idiopathic Pulmonary Fibrosis (IPF): a possible new biomarker of disease? (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paola Rogliani?
Paola Rogliani is affiliated with the following schools:
